Feed ORX.ST
OR
Orexo AB
ORX.ST · STO
14.68 kr +2.37% (+0.34 kr)
1M -36.86%
Market Cap 515.7M kr
P/E Ratio -
Div. Yield -
ROE 57.54%
Bulios Fair Price
8.28 kr
43.6% downside
Preț actual
14.68 kr
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile ORX.ST sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
78 /100
Cheap P/B 1.05x
P/FCF 2.98x
P/S 19.83x
Growth
22 /100
Declining Book val. growth 36.26%
Rev. growth 65.34%
FCF growth N/A
Profitability
30 /100
Weak FCF margin 665.39%
Op. margin 1,334.23%
Gross margin 213.46%
Quality
0 /100
Poor Asset turnover 0.02x
ROA 9.96%
ROIC 34.86%
Debt
46 /100
Moderate Current ratio 3.70x
Int. coverage -7.02x
Debt/Equity 1.00x
Stability
36 /100
Moderate Profitable years 0
EPS volatility 52.14%
Beta 0.89x
Întreabă StockBot despre ORX.ST
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Nikolaj Sørensen
Employees
61
Headquarters
Uppsala
Evenimente viitoare
22 OCT.
Earnings
Upcoming earnings report